First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

310

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2028

Conditions

Participants With Advanced Solid Tumor Malignancies

Interventions

DRUG

VBC101

Trial Locations (1)

NEXT Oncology, San Antonio

All Listed Sponsors

lead

VelaVigo Bio Inc

INDUSTRY

NCT07136779 - First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies | Biotech Hunter | Biotech Hunter